Cullen/Frost Bankers’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8K | Hold |
2,000
| – | – | ﹤0.01% | 1085 |
|
|
2025
Q1 | $1.44K | Hold |
2,000
| – | – | ﹤0.01% | 1189 |
|
|
2024
Q4 | $2.06K | Hold |
2,000
| – | – | ﹤0.01% | 1146 |
|
|
2024
Q3 | $2.68K | Hold |
2,000
| – | – | ﹤0.01% | 1090 |
|
|
2024
Q2 | $2.6K | Buy |
+2,000
| New | +$2.6K | ﹤0.01% | 1072 |
|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$2.42K | – | 1169 |
|
|
2023
Q3 | $2.42K | Hold |
2,000
| – | – | ﹤0.01% | 1048 |
|
|
2023
Q2 | $2.9K | Hold |
2,000
| – | – | ﹤0.01% | 1023 |
|
|
2023
Q1 | $2.9K | Hold |
2,000
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q4 | $3.46K | Hold |
2,000
| – | – | ﹤0.01% | 992 |
|
|
2022
Q3 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 1024 |
|
|
2022
Q2 | $1K | Buy |
2,000
+1,000
| +100% | +$500 | ﹤0.01% | 1043 |
|
|
2022
Q1 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 953 |
|
|
2021
Q4 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 919 |
|
|
2021
Q3 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 1004 |
|
|
2021
Q2 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 1033 |
|
|
2021
Q1 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 881 |
|
|
2020
Q4 | $19K | Buy |
+1,000
| New | +$19K | ﹤0.01% | 851 |
|